Videos
Click on the topics below to see interviews with Dr Martijn Arns, Global Chief Scientific Advisor for the neuroCare Group and neuromodulation expert
Clinical Indications for rTMS
The Potential Side Effects of rTMS
Typical Reponse & Remission Rates of rTMS
Key Differences Between rTMS and Electroconvulsive Therapy
Key Differences Between High Frequency & Low Frequency rTMS Protocols
The Principal for Choosing the Dorsolateral Prefrontal Cortex for rTMS
Localising The Exact Point for Maximum Stimulation for rTMS
neuroCare is innovating mental health and performance by personalising therapy following a detailed assessment. neuroCare’s objective, measurable and effective approach is based on our natural ability to learn (neuroplasticity) and technology to accelerate the learning (neuromodulation).
To learn more about what we do worldwide
www.neurocaregroup.com
neuroCademy Professional Training & Science
www.neurocademy.com
